References
- Fukunishi S, Yoh K, Kamae S, Yoshiya S. Beta 2-microglobulin amyloid deposit in HLA-B27 transgenic rats. Mod Rheumatol. 2007;17:380–4.
- Gejyo F, Yamada T, Odani S, Nakagawa Y, Arakawa M, Kuni-tomo T, et al. A new form of amyloid protein associated withb chronic hemodialysis was identified as beta 2-microglobulin. Biochem Biophys Res Commun. 1985;129: 701–6.
- Cruickshank B. Pathology of ankylosing spondylitis. Bull Rheum Dis. 1960;10:211–4.
- Lehtinen K. Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis. Ann Rheum Dis. 1993;52:174–6.
- WTCCC TASC. A genome-wide scan of 14,000 non-synony-mous coding SNPs in 5,500 individuals: the Wellcome Trust Case Control Consortium. Nat Genet. 2007;39:1329–37.
- Hammer RE, Maika SD, Richardson JA, Tang JP, Taurog JD. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2 m: an animal model of HLA-B27-associated human disorders. Cell. 1990;63: 1099–112.
- Taurog JD, Maika SD, Satumtira N, Dorris ML, McLean IL, Yanagisawa H, et al. Inflammatory disease in HLA-B27 trans-genic rats. Immunol Rev. 1999;169:209–23.
- Tran TM, Dorris ML, Satumtira N, Richardson JA, Hammer RE, Shang J, et al. Additional human beta2 m curbs HLA-B27 mis-folding and promotes arthritis and spondylitis without colitis in male HLA-B27 transgenic rats. Arthritis Rheum. 2006;54:1317–27.
- Ziegler A, Loll B, Misselwitz R, Uchanska-Ziegler B. Implica-tions of structural and thermodynamic studies of HLA-B27 subtypes exhibiting differential association with ankylosing spondylitis. In: López-Larrea C, editor. Molecular mechanisms of spondyloarthropathies. Austin: Landes Bioscience; 2008 (in press).
- Uchanska-Ziegler B, Ziegler A. Ankylosing spondylitis: a fign-deposition disease? Trends Immunol. 2003;24:73–6.